Doctor Mazen Hanna
Cleveland Clinic Main Campus, Cleveland (United States of America)
Follow
Contributor content
Presentation
Survival in a contemporary, real-world, matched cohort of patients with transthyretin amyloid cardiomyopathy treated vs not treated with tafamidis
Presentation
Vutrisiran reduces days lost to death and/or hospitalization versus placebo in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial
Presentation
Expert exchange: treating hATTR polyneuropathy patients with a mixed phenotype (polyneuropathy and cardiomyopathy)
Presentation
